EQSAdhoc APONTIS PHARMA AG Key word Change in ForecastProfit Warning APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and mediumterm planning for 2026 27Jul2023 2210 CETCEST Disclosure of an
EQS-News: APONTIS PHARMA AG / Key word: Product Launch
APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development partnership with Zentiva Group for. | May 8, 2023
EQS-Ad-hoc: APONTIS PHARMA AG / Key word: Forecast/Change in Forecast
APONTIS PHARMA AG adjusts forecast for fiscal year 2023
02-May-2023 / 21:50 CET/CEST
Disclosure of an inside information. | May 2, 2023
EQS-News: APONTIS PHARMA AG / Key word: Product Launch
APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property. | April 12, 2023